SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676454
Filing Date
2016-08-09
Accepted
2016-08-09 13:44:48
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d225682d10q.htm 10-Q 318504
2 EX-10.1 d225682dex101.htm EX-10.1 374518
3 EX-10.2 d225682dex102.htm EX-10.2 42758
4 EX-31.1 d225682dex311.htm EX-31.1 5983
5 EX-31.2 d225682dex312.htm EX-31.2 5955
6 EX-32.1 d225682dex321.htm EX-32.1 3770
7 EX-32.2 d225682dex322.htm EX-32.2 3740
  Complete submission text file 0001193125-16-676454.txt   2621743

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ccxi-20160630.xml EX-101.INS 397890
9 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20160630.xsd EX-101.SCH 29088
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20160630_cal.xml EX-101.CAL 46794
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20160630_def.xml EX-101.DEF 59481
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20160630_lab.xml EX-101.LAB 223040
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20160630_pre.xml EX-101.PRE 153670
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 161817215
SIC: 2834 Pharmaceutical Preparations